U.S. Physical Therapy, Inc. (NYSE:USPH) Director Bernard A. Harris, Jr. Sells 2,000 Shares

U.S. Physical Therapy, Inc. (NYSE:USPH) Director Bernard A. Harris, Jr. sold 2,000 shares of the firm’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total value of $185,900.00. Following the completion of the sale, the director now owns 16,726 shares of the company’s stock, valued at approximately $1,554,681.70. This trade represents a 10.68 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

U.S. Physical Therapy Stock Performance

USPH opened at $89.95 on Friday. The company has a market capitalization of $1.36 billion, a price-to-earnings ratio of 95.69, a P/E/G ratio of 4.15 and a beta of 1.38. The business’s 50-day moving average price is $84.19 and its two-hundred day moving average price is $91.17. U.S. Physical Therapy, Inc. has a 1 year low of $76.18 and a 1 year high of $113.63. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.88.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. During the same quarter in the previous year, the company posted $0.76 EPS. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. Equities analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Stockholders of record on Friday, November 15th will be issued a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 1.96%. The ex-dividend date of this dividend is Friday, November 15th. U.S. Physical Therapy’s payout ratio is presently 187.23%.

Institutional Trading of U.S. Physical Therapy

Large investors have recently added to or reduced their stakes in the company. Precision Wealth Strategies LLC increased its position in U.S. Physical Therapy by 5.1% during the third quarter. Precision Wealth Strategies LLC now owns 2,824 shares of the company’s stock worth $239,000 after buying an additional 137 shares during the last quarter. Texas Permanent School Fund Corp boosted its stake in shares of U.S. Physical Therapy by 1.3% during the 1st quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company’s stock worth $1,480,000 after acquiring an additional 170 shares during the period. First Horizon Advisors Inc. increased its holdings in shares of U.S. Physical Therapy by 18.6% during the 2nd quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock worth $110,000 after acquiring an additional 186 shares during the last quarter. Louisiana State Employees Retirement System raised its stake in U.S. Physical Therapy by 2.7% in the 2nd quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock valued at $702,000 after acquiring an additional 200 shares during the period. Finally, Martin Capital Advisors LLP lifted its holdings in U.S. Physical Therapy by 1.6% during the 3rd quarter. Martin Capital Advisors LLP now owns 13,138 shares of the company’s stock valued at $1,112,000 after purchasing an additional 201 shares during the last quarter.

Analyst Upgrades and Downgrades

Several research firms have recently commented on USPH. Bank of America reissued a “neutral” rating and issued a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Finally, Barrington Research restated an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 7th.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.